노을

376930KOSDAQ

66.7 / 100

Reference Date: 2026-09-08

Financial Score20.5 / 40

News Sentiment19.2 / 25

Momentum17.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 159.2% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Noul is a company specializing in the development and sale of on-device AI solutions, 'miLab™', for blood and cancer diagnostics. By automating microscopic pathology processes and integrating AI-based diagnostic technology, miLab™ enables high-precision diagnostics even in environments lacking specialized personnel or infrastructure. The solution currently offers three applications—malaria diagnosis, peripheral blood smear analysis, and cervical cell analysis—and targets the mid-sized diagnostic lab market, where it holds a competitive advantage due to its offline capabilities and cost-effectiveness.

Number of Employees

130people

Average Salary

73.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.65Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

-87.04Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

21.04Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲89.2% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼14.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -72.7% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 4Neutral 0Negative 2Average Sentiment Score 76.7

Positive
노을 ‘마이랩’, 베냉 국가 말라리아 진단 체계 정식 편입…공공조달.....
노을의 AI 기반 말라리아 진단 솔루션 마이랩이 베냉의 공식 말라리아 진단 체계에 편입되어 공공의료 분야에서의 활용이 확대되며, 빠른 검사 시간 단축과 높은 정확도를 통해 글로벌 시장 진출 가속화를 기대할 수 있다.
Negative
[노을 딥시크②]동전주 병합이 끝이 아니다…'3중 관리종목 리스크'
노을의 주가 하락으로 인한 관리종목 지정 이후 주식병합에도 불구하고 상장 유지에 대한 불확실성이 높아져 부정적 영향이 예상됩니다.
Positive
노을, 액면병합 따른 주권매매거래 정지 해제
노을의 액면병합으로 인한 주권매매거래 정지 해제로 투자자들의 거래 편의성이 개선되어 긍정적 영향 기대.

Detailed Momentum

52-week position5.0Point

52w mid range (41%)

Current 1,620Won52-week high 3,45852-week low 334

1-month return6.0Point

1m +159.20% (strong rise)

Volume trend6.0Point

Volume surge

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral주권매매거래정지해제 (액면병합 주권 변경상장)2026-09-04
Neutral주식등의대량보유상황보고서(일반)2026-08-19
Neutral주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)2026-08-14
Neutral반기보고서 (2026.06)2026-08-13